Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 4, 1998, Pages 535-541

  Blacher, Jacques ^a   Demuth, Karine ^a   Guerin, Alain P ^b   Safar, Michel E ^a   Moatti, Nicole ^a   London, Gerard M ^b  

^a HÔPITAL BROUSSAIS   (France)

^b Hopital Manhes   (France)

Author keywords

End stage renal disease; Endothelin; Homocysteine; Pulse wave velocity

Indexed keywords

CHOLESTEROL; FIBRINOGEN; HEMOGLOBIN; HOMOCYSTEIC ACID; TRIACYLGLYCEROL;

ADULT; ARTERY CALCIFICATION; ARTERY COMPLIANCE; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; BODY MASS; CAROTID ARTERY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART WEIGHT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RADIAL ARTERY;

EID: 0031976591     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.4.535     Document Type: Article

References (14)

1. Nichols WW, O'Rourke MF. MacDonald's Blood Flow in Arteries: Theoretical, Experimental, and Clinical Principles. 3rd ed. London, England: Arnold; 1990:77-142, 216-269, 283-359, 398-437.
2. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F. Cardiac and arterial interactions in end-stage renal disease. Kidney Int. 1996;50:600-608.
3. Mourad JJ, Girerd X, Boutouyrie P, Laurent S, Safar ME, London G. Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension. 1997;30:1425-1430.
4. Acar C, Jebara V, Porthogese M. Comparative anatomy and histology of the radial artery and the internal thoracic artery: implication for coronary bypass. Surg Radiol Anat. 1991;13:283-288.
5. Lindner A, Charra B, Sherrard DJ, Sribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974;290:697-701.
6. Barenbrock M, Spieker C, Laske V, Rahn K-H. Studies of the vessel wall properties in hemodialysis patients. Kidney Int. 1994;45:1397-1400.
7. London GM, Marchais SJ, Guerin AP, Metivier F, Safar ME, Fabiani F, Froment L. Salt and water retention and calcium blockade in uremia. Circulation. 1990;82:105-113.
8. Safar ME, Asmar RG, Benetos A, London GM, Levy BI. Sodium, large arteries and diuretic compounds in hypertension. J Hypertens. 1992;10(suppl 6):S133-S136.
9. Gafter U, Battler A, Eldar M, Zevin D, Neufeld HN, Levi J. Effect of hyperparathyroidism on cardiac function in patients with end-stage renal disease. Nephron. 1985;41:31-33.
10. Amann K, Flechtenmacher C, Tomig J, Schwarz U, Mall G, Ritz E. Permissive effect of PTH on vascular wall hypertrophy on intramyocardial arteries in experimental renal failure. Med Klin. 1996;91:551-556.
11. Koyama Y, Tabata T, Nishizawa Y, Inoue T, Morii H, Yamaji T. Plasma endothelin levels in patients with uraemia. Lancet. 1989;1:991-992.
12. Warrens AN, Cassidy MJD, Takahashi K, Ghatei MA, Bloom SR. Endothelin in renal failure. Nephrol Dial Transplant. 1990;5:418-422.
13. Chauveau P, Chadefaux B, Coudé M, Aupetit J, Hannedouche T, Kamoun P, Jungers P. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int. 1993;43(suppl 41):S-72-S-77.
14. Bostom AG, Shemin D, Lapane KL, Miller JW, Sutherland P, Nadeau M, Seyoum E, Hartman W, Prior R, Wilson PWF, Selhub J. Hyperhomo-cystinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study. Atherosclerosis. 1995;114:93-103.